Xencor, Inc Public Float
Xencor, Inc (XNCR) had Public Float of $555.94 million as of 2025-06-30, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-25
- 2025-06-30: Entity Public Float $555.94M.
- 2024-06-30: Entity Public Float $1.16B.
- 2023-06-30: Entity Public Float $1.50B.
- 2022-06-30: Entity Public Float $1.62B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $555.94M 10-K · filed 2026-02-25 |
| 2024-06-30 | $1.16B 10-K · filed 2025-02-27 |
| 2023-06-30 | $1.50B 10-K/A · filed 2025-02-24 |
| 2022-06-30 | $1.62B 10-K · filed 2023-02-27 |
| 2021-06-30 | $2.00B 10-K · filed 2022-02-24 |
| 2020-06-30 | $1.84B 10-K · filed 2021-02-24 |
| 2019-06-28 | $2.29B 10-K · filed 2020-02-25 |
| 2018-06-30 | $2.05B 10-K · filed 2019-02-26 |
| 2017-06-30 | $939.65M 10-K · filed 2018-02-28 |
| 2016-06-30 | $769.08M 10-K · filed 2017-03-01 |
| 2015-06-30 | $490.43M 10-K · filed 2016-03-08 |
| 2014-06-30 | $151.51M 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |